Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,790 total articles
Alibaba is building agentic AI capabilities (Qwen / Accio Work / Wukong) that can operate as digital employees for enterprises. The market has focused on macro and regulatory noise and is underpricing the revenue and enterprise-engagement optionality from agentic deployments. Technicals and sentiment suggest a tactical long with defined risk-reward…
Rolls‑Royce (RYCEY) is showing improving commercial aerospace aftermarket activity, steady defense demand and growing relevance in small modular reactors (SMRs). Technicals and liquidity patterns favor a bounce toward the 52‑week high. I’m upgrading to a buy for a mid‑term trade: entry $17.10, stop $15.50, target $19.50 over ~45 trading days, with …
I upgrade Amazon to a buy and propose a mid-term long trade. AWS's AI tailwind, improving momentum indicators and a valuation that still looks reasonable at ~30x earnings justify a tactical entry at $225.47. Target $255 with a $210 stop; keep position size disciplined given recent FCF weakness and macro risks.
DISCO (DSCSY) reported Q4 above management guidance and the stock sits well below its 52-week high despite a market cap of about $44.2B and a forward-looking memory-market tailwind. This trade idea lays out a mid-term (45 trading days) buy with precise entry, stop and target, a rationale tied to semicap demand and technical setup, and a balanced li…
Powell Industries has gone from deep cyclicality to a leadership position in custom electrical systems, driven by a $1.6 billion backlog, expanding automation capabilities, and steady dividend hikes. The stock is at its 52-week high and shows bullish momentum, but valuation is rich versus history. This is a swing trade: initiate a cautious long wit…
Eli Lilly's market leadership in GLP-1 obesity therapies and an expanding immunology pipeline justify a tactical long. The shares trade at a premium (market cap ~$895B, P/E ~41.5) but generate strong free cash flow and superior ROE. I'll go long LLY at $940 with a $1,100 target and $880 stop, structured for a long-term (180 trading days) hold while…
Diebold Nixdorf (DBD) looks set to benefit from renewed investor attention tied to expected index inclusion and a steady operational recovery. With positive free cash flow, improving retail product sales, and an EV/EBITDA of 9, the risk/reward favors a tactical long over the next several months. Entry: $80.00, Target: $95.00, Stop: $72.00.
Nvidia remains the dominant GPU and AI-platform supplier. Recent strategic moves — including a $2 billion partnership to cement optical interconnect and custom silicon access — plus massive free cash flow and ultra-high profitability make 2026 a plausible inflection year. The stock is expensive on multiples but backed by cash generation, low levera…
Micron is at the center of a structural memory shortage for AI workloads. Strong cash flow, high ROE, and a still-reasonable multiple create an asymmetric risk/reward. This trade idea outlines a tactical long with clear entry, stop and target and explains the catalysts and risks that will determine the outcome.
Magnolia Oil & Gas (MGY) trades at roughly $5.57B market cap with trailing free cash flow of $398.8M. Under a conservative 2026 strip scenario we model >$700M in FCF, which would cut P/FCF to the high-single digits and leave room for dividend hikes, buybacks or multiple expansion. Trade idea: initiate a long with a measured stop and a $35 target ov…
STAAR Surgical's preliminary Q1 2026 net sales of over $90 million - more than double the year-ago period - and an expanded FDA age label materially improve the bull case after shareholders rejected Alcon's takeover. The share price gap higher looks justified, but negative free cash flow and regional headwinds keep risk elevated. This is a tactical…
NovaBridge Biosciences ($NBP) trades at a $281M market cap with a heavy clinical focus in oncology and ophthalmology. Positive data on immuno-oncology assets have already moved sentiment; a favorable Givastomig readout or advancement could re-rate the stock meaningfully from its current $2.44 handle. This is a tactical swing trade: entry at $2.44, …
Morgan Stanley (MS) just proved it can pivot into new growth channels while trading at modest multiples. The firm’s launch of a low-fee spot Bitcoin ETF and a timely private credit fund have re-energized the stock. At $176, MS looks like a reasonable tactical long with a clear stop and a $200 target over the next 180 trading days, provided macro st…
GE Aerospace's portfolio of engines, services and defense systems is producing predictable free cash flow that the market still undervalues. With a $323B market cap, $7.26B in free cash flow and a services-led aftermarket ramp, the stock can be bought around $308 with a clear stop and a $360 target as the market re-rates durability into valuation.
Anthropic's 04/08/2026 Project Glasswing announcement rewrites the debate about AI-driven attacks and defenses. CrowdStrike's cloud-native Falcon platform, $5.25B ARR scale, and fresh $500M buyback increase create a high-conviction long trade: enter near $425, stop at $365, target $520 over the next 180 trading days.
Broadcom's blend of custom AI silicon, high-margin infrastructure software and a cash-rich balance sheet make its current sell-off a tactical buying opportunity. Valuation is rich but supported by exceptional profitability: ROE ~31%, free cash flow of $28.9B and enterprise value of ~$1.712T. This trade proposes a medium-term long with clear entry, …
Delta shares have run into a volatile patch after a big intraday swing. I recommend a tactical short over the next several trading sessions to exploit stretched intraday moves, while remaining constructive on Delta over the next 6-12 months given attractive valuation, healthy free cash flow, and a strong balance sheet.
Expand Energy appears priced for weakness despite an active project pipeline and improving power fundamentals. We think a mid-term swing trade captures upside as near-term catalysts re-ignite investor interest. Entry $6.50, target $9.75, stop loss $5.25.
Paysign delivered a clear earnings beat and 2026 guide that leans on continued pharma and plasma momentum. At roughly $330M market cap and meaningful free cash flow, the market is beginning to price higher margins into the equity. This trade idea lays out an actionable long with an entry at $5.80, a $7.00 target and a $4.80 stop for a mid-term (45 …
Itaú Unibanco's combination of aggressive capital returns, a healthy dividend yield and improving technicals support a long swing trade. At $8.82 the ADSs look reasonably priced given a $97.35B market cap, a P/E of 12.2 and a 5.9% yield. We set an entry at $8.80, a stop at $8.00 and a target at $10.00 for a mid-term run tied to buyback execution an…
New Mountain Finance (NMFC) trades below book with a double-digit yield and conservative portfolio metrics relative to BDC peers. We outline a long trade with entry, stop and target for a long-term horizon (180 trading days) while mapping the key catalysts and risks that will determine success.
Eli Lilly’s Foundayo approval (04/06/2026) changes competitive math for obesity and diabetes drugs, but Novo Nordisk’s subscription pricing, a modest buyback and a 3.33% dividend create an asymmetric risk-reward at current levels. We lay out a long trade with clear entry, stop and target and explain the fundamental and technical drivers that justif…
Cal-Maine bought Creighton Brothers for $128.5M, adding 3.2M laying hens and processing capacity. The market has reacted, but valuation metrics - P/E ~5.3, EV/EBITDA ~3.4 and EV/Sales <1 - suggest the acquisition's earnings and strategic benefits are not fully priced. This is a position-sized long with defined entry, stop and target and a 120-tradi…
UBTRF printed a clean technical and sentiment setup after a stronger-than-expected update. Price sits above near-term EMAs, MACD shows bullish momentum, and short interest has spiked — creating a two-way opportunity. This is a tactical mid-term long for disciplined traders who accept OTC liquidity and execution risk.
Robert Half is paying a near-10% yield today while generating roughly $267M in free cash flow and carrying minimal reported debt. The business is cyclical, but recent sequential improvement in talent solutions and a large Protiviti consulting franchise give upside if hiring stabilizes. This trade idea outlines an entry at $24.00, a conservative sto…
